These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 959301)

  • 1. [Theoretical aspects of ascertaining parameters of action of biologically active compounds].
    Barth A; Franke R; Börnert D
    Pharmazie; 1976 Jun; 31(6):396-401. PubMed ID: 959301
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative structure activity relationships of analgesics, narcotic antagonists, and hallucinogens: introduction.
    NIDA Res Monogr; 1978; (22):1-5. PubMed ID: 101878
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of competitive ligand binding results in QSAR studies.
    Gómez-Jeria JS
    Farmaco Sci; 1985 May; 40(5):299-302. PubMed ID: 4007152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A theoretical approach to structure-activity relationships. Some implications for the concept of optimal lipophilicity [proceedings].
    Dearden JC; Townend MS
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():13P. PubMed ID: 12286
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in Hansch analysis].
    Guo ZR
    Yao Xue Xue Bao; 1983 Mar; 18(3):234-40. PubMed ID: 6349253
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic modeling in vivo.
    Holford NH; Sheiner LB
    Crit Rev Bioeng; 1981; 5(4):273-322. PubMed ID: 7023829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rate.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 Jun; 41(6):369-77. PubMed ID: 3763679
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronoavailability: a theoretical method of studying chronopharmacology].
    Hecquet B
    C R Acad Sci III; 1986; 302(8):293-5. PubMed ID: 3085882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative dependences for expressing the relationship between the pharmacological effect and the pharmacokinetic parameters of drugs].
    Mikhaĭlova D; Iamboliev I
    Eksp Med Morfol; 1982; 21(3):105-10. PubMed ID: 6756890
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled-release drug delivery systems and sustained preparations].
    Xi NZ
    Yao Xue Xue Bao; 1984 Sep; 19(9):715-9. PubMed ID: 6536186
    [No Abstract]   [Full Text] [Related]  

  • 11. Linearity and superposition in pharmacokinetics.
    Thron CD
    Pharmacol Rev; 1974 Mar; 26(1):3-31. PubMed ID: 4133328
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative structure-activity relationships. IV. Non-linear dependence of biological activity on hydrophobic character: a new model.
    Kubinyi H
    Arzneimittelforschung; 1976; 26(11):1991-7. PubMed ID: 1037231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic aspects relevant to biopharmaceutics].
    Segre G
    Ann Ist Super Sanita; 1982; 18(3):533-40. PubMed ID: 7187841
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental procedure for estimating the dissociation constant of noncompetitive interactants. Part I.
    Orsetti M
    Boll Soc Ital Biol Sper; 1986 Jan; 62(1):51-7. PubMed ID: 3718726
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of pharmacologically active metabolites in drug discovery and development.
    Fura A
    Drug Discov Today; 2006 Feb; 11(3-4):133-42. PubMed ID: 16533711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of pharmacokinetics in clinical pharmacology and biopharmaceutics].
    Xi NZ
    Yao Xue Xue Bao; 1983 Feb; 18(2):151-60. PubMed ID: 6613595
    [No Abstract]   [Full Text] [Related]  

  • 17. [Utilization of analog computers in the development of dosage forms].
    Frömming KH; Lippold B; Garrett ER
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1971 Sep; 41(9):205-47. PubMed ID: 4939073
    [No Abstract]   [Full Text] [Related]  

  • 18. A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry.
    Martin YC
    J Med Chem; 1981 Mar; 24(3):229-37. PubMed ID: 7265109
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fundamental aspects of the binding of drugs to circulating proteins].
    Houin G; Saivin S
    Ann Med Interne (Paris); 1994; 145(5):352-6. PubMed ID: 7985948
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative structure-pharmacokinetics relationships and their importance in drug design, possibilities and limitations.
    Seydel JK
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):571-81. PubMed ID: 6513673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.